EXAGEN INC. Capital Expenditures
EXAGEN INC. (XGN) reported Capital Expenditures of $771.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- EXAGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $543.00K, a 159.81% increase year-over-year.
- EXAGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $228.00K, a 101.77% increase year-over-year.
- EXAGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $44.00K, a 69.86% decline year-over-year.
- EXAGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $275.00K, a 87.07% increase year-over-year.
- EXAGEN INC. payments to acquire property, plant, and equipment for fiscal 2025 was $641.00K, a 24.47% increase from fiscal 2024.
- EXAGEN INC. payments to acquire property, plant, and equipment for fiscal 2024 was $515.00K, a 37.80% decline from fiscal 2023.
- EXAGEN INC. payments to acquire property, plant, and equipment for fiscal 2023 was $828.00K, a 80.82% decline from fiscal 2022.
- EXAGEN INC. payments to acquire property, plant, and equipment for fiscal 2022 was $4.32M, a 82.19% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $543.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $771.00K 10-Q · filed 2026-08-04 | $815.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $228.00K 10-Q · filed 2026-05-11 | $272.00K derived: sum of 2 quarters · filed 2026-05-11 | $547.00K derived: sum of 3 quarters · filed 2026-05-11 | $756.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $319.00K derived: sum of 2 quarters · filed 2026-03-10 | $528.00K derived: sum of 3 quarters · filed 2026-08-04 | $641.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $484.00K derived: sum of 2 quarters · filed 2026-08-04 | $597.00K 10-Q · filed 2025-11-04 | $743.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $322.00K 10-Q · filed 2026-08-04 | $468.00K derived: sum of 3 quarters · filed 2026-08-04 | $615.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $113.00K 10-Q · filed 2026-05-11 | $259.00K derived: sum of 2 quarters · filed 2026-05-11 | $406.00K derived: sum of 3 quarters · filed 2026-05-11 | $542.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $293.00K derived: sum of 2 quarters · filed 2026-03-10 | $429.00K derived: sum of 3 quarters · filed 2026-03-10 | $515.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $283.00K derived: sum of 2 quarters · filed 2025-11-04 | $369.00K 10-Q · filed 2025-11-04 | $475.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $222.00K 10-Q · filed 2025-07-29 | $328.00K derived: sum of 3 quarters · filed 2025-07-29 | $330.00K derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $86.00K 10-Q · filed 2025-05-05 | $192.00K derived: sum of 2 quarters · filed 2025-05-05 | $194.00K derived: sum of 3 quarters · filed 2025-05-05 | $518.00K derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $108.00K derived: sum of 2 quarters · filed 2025-03-11 | $432.00K derived: sum of 3 quarters · filed 2025-03-11 | $828.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $326.00K derived: sum of 2 quarters · filed 2024-11-12 | $722.00K 10-Q · filed 2024-11-12 | $1.13M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $720.00K 10-Q · filed 2024-08-05 | $1.13M derived: sum of 3 quarters · filed 2024-08-05 | $2.00M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $396.00K 10-Q · filed 2024-05-13 | $802.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.68M derived: sum of 3 quarters · filed 2024-05-13 | $3.63M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.28M derived: sum of 2 quarters · filed 2024-03-18 | $3.23M derived: sum of 3 quarters · filed 2024-03-18 | $4.32M 10-K · filed 2024-03-18 |
| 2022-09-30 | $879.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.83M derived: sum of 2 quarters · filed 2023-11-13 | $3.91M 10-Q · filed 2023-11-13 | $4.98M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $3.03M 10-Q · filed 2023-08-07 | $4.10M derived: sum of 3 quarters · filed 2023-08-07 | $4.52M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $1.09M 10-Q · filed 2023-05-15 | $2.15M derived: sum of 2 quarters · filed 2023-05-15 | $2.58M derived: sum of 3 quarters · filed 2023-05-15 | $3.29M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $1.49M derived: sum of 2 quarters · filed 2023-03-20 | $2.20M derived: sum of 3 quarters · filed 2023-03-20 | $2.37M 10-K · filed 2023-03-20 |
| 2021-09-30 | $425.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $1.14M derived: sum of 2 quarters · filed 2022-11-21 | $1.31M 10-Q · filed 2022-11-21 | $1.31M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $714.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21 | $881.00K 10-Q/A · filed 2022-11-21 | $886.00K derived: sum of 3 quarters · filed 2022-11-21 | $1.10M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $167.00K 10-Q · filed 2022-05-11 | $172.00K derived: sum of 2 quarters · filed 2022-05-11 | $385.00K derived: sum of 3 quarters · filed 2022-05-11 | $538.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $218.00K derived: sum of 2 quarters · filed 2022-03-22 | $371.00K derived: sum of 3 quarters · filed 2022-03-22 | $455.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $366.00K derived: sum of 2 quarters · filed 2021-11-10 | $450.00K 10-Q · filed 2021-11-10 | $476.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $237.00K 10-Q · filed 2021-08-09 | $263.00K derived: sum of 3 quarters · filed 2021-08-09 | $265.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $84.00K 10-Q · filed 2021-05-11 | $110.00K derived: sum of 2 quarters · filed 2021-05-11 | $112.00K derived: sum of 3 quarters · filed 2021-05-11 | $124.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $28.00K derived: sum of 2 quarters · filed 2021-03-16 | $40.00K derived: sum of 3 quarters · filed 2021-03-16 | $403.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $14.00K derived: sum of 2 quarters · filed 2020-11-10 | $377.00K 10-Q · filed 2020-11-10 | $448.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $375.00K 10-Q · filed 2020-07-28 | $446.00K derived: sum of 3 quarters · filed 2020-07-28 | |
| 2019-03-31 | $363.00K 10-Q · filed 2020-05-11 | $434.00K derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $199.00K 10-K · filed 2020-03-25 | ||
| 2018-09-30 | $128.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |